Blister pack with dollars instead of pills From 2011-2019, large drug companies had areturn on investment capital of 17.3 percent, compared tothe average ROIC across all other industries of 11.5percent. (Photo: Shutterstock)

Pharma has been countering the call for government-mandatedprice restrictions by arguing that lowerindustry revenues would stymie development of needed drugs.

A group of researchers at the West Health Policy Center andJohns Hopkins Bloomberg School of Public Health say that's a lot ofhooey–claiming they have the data to back that up.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Katie Kuehner-Hebert

Katie Kuehner-Hebert is a freelance writer based in Running Springs, Calif. She has more than three decades of journalism experience, with particular expertise in employee benefits and other human resource topics.

Consumer Driven Health Care
Core and Group Health
Health Care Reform
Cost-Containment
Employer-Paid
Investment Instruments